SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant investor interest as a proxy for upcoming high-profile IPOs like SpaceX and Anthropic, with the community actively debating whether the fund's current premium to net asset value represents a fair entry point or an overvaluation compared to peers. Traders are closely monitoring for potential catalysts related to official IPO filings, sparking active discussions about the fund's portfolio concentration and its potential for a major price move.

The Shrimp Army

SHRIMPS is gaining traction as part of a broader, speculative 'ocean-themed' meme coin trend that has captured community attention for its rapid price volatility. Traders are actively debating whether the token has long-term potential or is another high-risk momentum play, with many emphasizing the need for quick profit-taking amid frequent rug-pull concerns.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is capturing investor attention as the community anticipates a significant breakout, with many bulls actively loading up on dips while speculating on long-term utility in the Web3 gaming and AI sectors. Traders are closely monitoring technical support levels and volume patterns, with much of the discussion focused on the potential for a rally despite recent market volatility.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently trending due to a contentious short report from Culper Research that alleges the company is engaged in channel stuffing and misleading financial reporting. While the stock has faced significant downward volatility, a vocal community of long-term investors is actively pushing back against the report, labeling it a manipulative hit piece and rallying around management's history of hitting financial targets, share buybacks, and robust growth forecasts.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining momentum as a critical DeFi infrastructure player, fueled by its role in distributing U.S. government macroeconomic data on-chain and its recent launch of a revenue-backed token buyback program. Community sentiment remains bullish, with investors focusing on the project's institutional adoption, its expansion into Real World Assets, and its increased retail accessibility through major exchange listings.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings Inc is facing intense downward pressure and negative investor sentiment as traders react to macroeconomic volatility, including concerns over potential inflation, interest rates, and geopolitical tensions. Despite recent partnership announcements, the stock is seeing significant short interest and underperforming compared to fintech peers, with many in the community expressing frustration over its persistent volatility and lack of sustained momentum.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root is facing intense downward pressure and hitting new lows, with the community actively debating whether the company is a failing business model nearing a bankruptcy-like state or an undervalued disruptor poised for a buyout. While bulls point to accelerating partnerships and potential for a significant squeeze before upcoming earnings, bears argue that management is intentionally draining capital through excessive stock-based compensation and unsustainable marketing spend.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin Corp (AMRN) is trending due to the Supreme Court's upcoming conference on January 9, 2026, to decide whether to hear the company's patent infringement case against Hikma, a pivotal moment for its U.S. IP protection. The community is actively debating the potential implications of a Supreme Court ruling on 'skinny label' usage, alongside ongoing discussions about the company's path to profitability and speculation surrounding a potential acquisition following the appointment of a financial advisor.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is experiencing a surge in investor interest and volatility driven by its strategic expansion into the healthcare sector through the acquisition of Diligent Robotics and continued deployments alongside major delivery platforms. The community remains highly active in debating the company's long-term growth potential and unit economics, with many monitoring short interest and technical breakouts as the stock attempts to sustain momentum following its presence at industry-wide technology showcases.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently seeing significant community interest ahead of a major data presentation at the AAD conference, where long-term results through Week 40 for their sonelokimab program are expected to be unveiled. Investors are closely tracking these upcoming results and rumored buyout interest from pharmaceutical giants, as the community debates whether the trial data will solidify the asset as a best-in-class treatment and trigger a major revaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is C3.ai Stock a Sell or Buy After the CFO Sold Over 15,000 Shares?

Key PointsCFO Hitesh Lath sold 15,248 Class A shares for ~$137,000 on March 16, 2026, at a weighted average price of around $8.98 per share...

C3.ai Stock Tumbles 16% Post Q3 Earnings: Buy the Dip or Fold?

AI stock slides after weak Q3 fiscal 2026. Can its restructuring and enterprise demand offset revenue declines and mounting losses ahead?

BigBear.ai vs. C3.ai: Which AI Stock Has More Upside Now?

Is BigBear.ai better positioned than C3.ai as acquisitions, defense spending and weak revenues reshape AI stocks?

Here's What Key Metrics Tell Us About C3.ai (AI) Q3 Earnings

The headline numbers for C3.ai (AI) give insight into how the company performed in the quarter ended January 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

C3.ai Target of Unusually Large Options Trading (NYSE:AI)

C3.ai, Inc. (NYSE:AI - Get Free Report) was the target of some unusual options trading activity on Friday. Traders bought 108,092 call options on the company. This represents an increase of approximately 78% compared to the average volume of 60,840 call options...

C3.ai (NYSE:AI) Chairman Sells $1,901,278.98 in Stock

C3.ai, Inc. (NYSE:AI - Get Free Report) Chairman Thomas Siebel sold 219,294 shares of the firm's stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $8.67, for a total transaction of $1,901,278.98. Following the sale, the chairman owned 722,362...

C3.ai (NYSE:AI) Chairman Thomas Siebel Sells 282,203 Shares

C3.ai, Inc. (NYSE:AI - Get Free Report) Chairman Thomas Siebel sold 282,203 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $8.86, for a total transaction of $2,500,318.58. Following the completion of the sale, the chairman owned...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI PR...

C3.ai, Inc. (NYSE:AI) Receives Average Rating of "Reduce" from Analysts

C3.ai, Inc. (NYSE:AI - Get Free Report) has been assigned a consensus rating of "Reduce" from the fifteen research firms that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommen...

C3.ai Tightens AI Pilot Strategy: What Does It Mean for Conversions?

AI tightens its AI pilot strategy, focusing on higher-value deployments to boost conversion rates and align with enterprise demand for measurable outcomes.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

Current Price	$8.28
Prev Close	$8.29
Open	$8.51
Dividend Yield	0.00%
50-Day Moving Average	$10.49
Beta	2.30
Avg. Volume	8.38M
PE Ratio	-2.62

52-Week High	$30.24
52-Week Low	$7.72
Market Capitalization	$1.2B
EPS (Annual)	-$2.24
Price to Book	1.66
Revenue Per Employee	$329,429.30

AI
C3.ai Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AI News

AIC3.ai Inc